BCAX Form 144: Insider sales recorded

BCAX (Rule 144 filing) — Notice of proposed sales of Common Stock by a reporting person and record of recent open-market dispositions.

Rhea-AI Filing Summary

BCAX (Rule 144 filing) — Notice of proposed sales of Common Stock by a reporting person and record of recent open-market dispositions. The filing lists proposed option exercises of 4,500 and 8,000 shares and five completed sales on 01/15/2026, 01/22/2026, 02/25/2026, 03/03/2026, and 03/16/2026 with per-line proceeds shown.

Insights

Securities Compliance Analyst

Routine Rule 144 notice and recent dispositions recorded; no new material corporate action.

The filing records proposed sales tied to option exercises (4,500 and 8,000 shares) and five executed dispositions by the reporting person, with each trade dated and gross proceeds listed. This is a compliance disclosure under resale rules.

Timing and cash treatment for the option exercises are stated by date; additional regulatory paperwork or broker reporting may follow as required.

Key Figures

Proposed exercise: 4,500 shares Proposed exercise: 8,000 shares Sale on 01/22/2026: 3,828 shares +4 more

7 metrics

Proposed exercise 4,500 shares Exercise of Stock Option dated <date>05/12/2024</date>

Proposed exercise 8,000 shares Exercise of Stock Option dated <date>04/15/2026</date>

Sale on 01/22/2026 3,828 shares Completed sale with proceeds <money>$69,295.99</money>

Sale on 02/25/2026 3,631 shares Completed sale with proceeds <money>$69,132.42</money>

Sale on 03/03/2026 17,392 shares Completed sale with proceeds <money>$315,892.64</money>

Sale on 03/16/2026 12,500 shares Completed sale with proceeds <money>$245,713.75</money>

Sale on 01/15/2026 149 shares Completed sale with proceeds <money>$2,684.98</money>

Key Terms

Exercise of Stock Option, Rule 144, Common

3 terms

Exercise of Stock Option financial

"Exercise of Stock Option | Issuer | 4500 | 05/12/2024"

Rule 144 regulatory

"Form type: 144 (implied by header and content)"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Common financial

"Common | UBS Financial Services, Inc Eleven Madison Avenue"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BCAX's Form 144 show about insider sales?

It shows proposed and completed sales of Common Stock by a reporting person. The filing lists five completed sales with share counts and proceeds and two option exercises noted as methods for acquiring shares.

How many shares were sold on 03/03/2026 in the BCAX filing?

The filing lists a sale of 17,392 shares on 03/03/2026. That line also shows gross proceeds of $315,892.64 tied to that executed disposition.

What option exercises are recorded in this Form 144 for BCAX?

The filing records two "Exercise of Stock Option" entries: 4,500 shares (05/12/2024) and 8,000 shares (04/15/2026), each labeled as cash exercises in the excerpt.

Who is the reporting person in the BCAX Form 144?

The reported seller is listed as Ryan Cohlhepp at the Boston address shown. Multiple executed sales are attributed to that reporting person in the excerpt.

Do the Form 144 lines include proceeds amounts for each sale?

Yes. Each completed-sale line in the excerpt includes a gross proceeds figure, for example $69,295.99 on 01/22/2026 and $245,713.75 on 03/16/2026, alongside share counts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:06 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034665
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Cohlhepp Ryan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc Eleven Madison Avenue 4th Floor New York NY 10010	12500	287250.00	65467187	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2024	Exercise of Stock Option	Issuer			4500	05/12/2024	Cash
Common	04/15/2026	Exercise of Stock Option	Issuer			8000	04/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	01/15/2026	149	2684.98
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	01/22/2026	3828	69295.99
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	02/25/2026	3631	69132.42
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	03/03/2026	17392	315892.64
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	03/16/2026	12500	245713.75

144: Remarks and Signature

Remarks
Date of Notice	04/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ryan Cohlhepp
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)